Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Medical Device Analytical Testing Outsourcing Market

ID: MRFR/MED/30738-HCR
100 Pages
Rahul Gotadki
Last Updated: April 06, 2026

Medical Device Analytical Testing Outsourcing Market Research Report By Testing Type (Biological Testing, Chemical Testing, Physical Testing, Sterilization Testing), By Device Type (In-Vitro Diagnostic Devices, Surgical Instruments, Patient Monitoring Devices, Therapeutic Equipment), By Service Type (Quality Control Testing, Regulatory Compliance Testing, Research and Development Testing, Stability Testing), By End User (Medical Device Manufacturers, Contract Research Organizations, Pharmaceutical Companies, Academic Institutions), By Test Phase (Preclinical Testing, Clinical Testing, Post-Market Surveillance) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Medical Device Analytical Testing Outsourcing Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Testing Type (USD Billion)
  49.     4.1.1 Biological Testing
  50.     4.1.2 Chemical Testing
  51.     4.1.3 Physical Testing
  52.     4.1.4 Sterilization Testing
  53.   4.2 Healthcare, BY Device Type (USD Billion)
  54.     4.2.1 In-Vitro Diagnostic Devices
  55.     4.2.2 Surgical Instruments
  56.     4.2.3 Patient Monitoring Devices
  57.     4.2.4 Therapeutic Equipment
  58.   4.3 Healthcare, BY Service Type (USD Billion)
  59.     4.3.1 Quality Control Testing
  60.     4.3.2 Regulatory Compliance Testing
  61.     4.3.3 Research and Development Testing
  62.     4.3.4 Stability Testing
  63.   4.4 Healthcare, BY End User (USD Billion)
  64.     4.4.1 Medical Device Manufacturers
  65.     4.4.2 Contract Research Organizations
  66.     4.4.3 Pharmaceutical Companies
  67.     4.4.4 Academic Institutions
  68.   4.5 Healthcare, BY Test Phase (USD Billion)
  69.     4.5.1 Preclinical Testing
  70.     4.5.2 Clinical Testing
  71.     4.5.3 Post-Market Surveillance
  72.   4.6 Healthcare, BY Region (USD Billion)
  73.     4.6.1 North America
  74.       4.6.1.1 US
  75.       4.6.1.2 Canada
  76.     4.6.2 Europe
  77.       4.6.2.1 Germany
  78.       4.6.2.2 UK
  79.       4.6.2.3 France
  80.       4.6.2.4 Russia
  81.       4.6.2.5 Italy
  82.       4.6.2.6 Spain
  83.       4.6.2.7 Rest of Europe
  84.     4.6.3 APAC
  85.       4.6.3.1 China
  86.       4.6.3.2 India
  87.       4.6.3.3 Japan
  88.       4.6.3.4 South Korea
  89.       4.6.3.5 Malaysia
  90.       4.6.3.6 Thailand
  91.       4.6.3.7 Indonesia
  92.       4.6.3.8 Rest of APAC
  93.     4.6.4 South America
  94.       4.6.4.1 Brazil
  95.       4.6.4.2 Mexico
  96.       4.6.4.3 Argentina
  97.       4.6.4.4 Rest of South America
  98.     4.6.5 MEA
  99.       4.6.5.1 GCC Countries
  100.       4.6.5.2 South Africa
  101.       4.6.5.3 Rest of MEA
  102. 5 SECTION V: COMPETITIVE ANALYSIS
  103.   5.1 Competitive Landscape
  104.     5.1.1 Overview
  105.     5.1.2 Competitive Analysis
  106.     5.1.3 Market share Analysis
  107.     5.1.4 Major Growth Strategy in the Healthcare
  108.     5.1.5 Competitive Benchmarking
  109.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  110.     5.1.7 Key developments and growth strategies
  111.       5.1.7.1 New Product Launch/Service Deployment
  112.       5.1.7.2 Merger & Acquisitions
  113.       5.1.7.3 Joint Ventures
  114.     5.1.8 Major Players Financial Matrix
  115.       5.1.8.1 Sales and Operating Income
  116.       5.1.8.2 Major Players R&D Expenditure. 2023
  117.   5.2 Company Profiles
  118.     5.2.1 Eurofins Scientific (FR)
  119.       5.2.1.1 Financial Overview
  120.       5.2.1.2 Products Offered
  121.       5.2.1.3 Key Developments
  122.       5.2.1.4 SWOT Analysis
  123.       5.2.1.5 Key Strategies
  124.     5.2.2 SGS SA (CH)
  125.       5.2.2.1 Financial Overview
  126.       5.2.2.2 Products Offered
  127.       5.2.2.3 Key Developments
  128.       5.2.2.4 SWOT Analysis
  129.       5.2.2.5 Key Strategies
  130.     5.2.3 Intertek Group plc (GB)
  131.       5.2.3.1 Financial Overview
  132.       5.2.3.2 Products Offered
  133.       5.2.3.3 Key Developments
  134.       5.2.3.4 SWOT Analysis
  135.       5.2.3.5 Key Strategies
  136.     5.2.4 TÜV SÜD AG (DE)
  137.       5.2.4.1 Financial Overview
  138.       5.2.4.2 Products Offered
  139.       5.2.4.3 Key Developments
  140.       5.2.4.4 SWOT Analysis
  141.       5.2.4.5 Key Strategies
  142.     5.2.5 Charles River Laboratories (US)
  143.       5.2.5.1 Financial Overview
  144.       5.2.5.2 Products Offered
  145.       5.2.5.3 Key Developments
  146.       5.2.5.4 SWOT Analysis
  147.       5.2.5.5 Key Strategies
  148.     5.2.6 Pace Analytical Services, LLC (US)
  149.       5.2.6.1 Financial Overview
  150.       5.2.6.2 Products Offered
  151.       5.2.6.3 Key Developments
  152.       5.2.6.4 SWOT Analysis
  153.       5.2.6.5 Key Strategies
  154.     5.2.7 Bureau Veritas (FR)
  155.       5.2.7.1 Financial Overview
  156.       5.2.7.2 Products Offered
  157.       5.2.7.3 Key Developments
  158.       5.2.7.4 SWOT Analysis
  159.       5.2.7.5 Key Strategies
  160.     5.2.8 Medpace Holdings, Inc. (US)
  161.       5.2.8.1 Financial Overview
  162.       5.2.8.2 Products Offered
  163.       5.2.8.3 Key Developments
  164.       5.2.8.4 SWOT Analysis
  165.       5.2.8.5 Key Strategies
  166.     5.2.9 Laboratory Corporation of America Holdings (US)
  167.       5.2.9.1 Financial Overview
  168.       5.2.9.2 Products Offered
  169.       5.2.9.3 Key Developments
  170.       5.2.9.4 SWOT Analysis
  171.       5.2.9.5 Key Strategies
  172.   5.3 Appendix
  173.     5.3.1 References
  174.     5.3.2 Related Reports
  175. 6 LIST OF FIGURES
  176.   6.1 MARKET SYNOPSIS
  177.   6.2 NORTH AMERICA MARKET ANALYSIS
  178.   6.3 US MARKET ANALYSIS BY TESTING TYPE
  179.   6.4 US MARKET ANALYSIS BY DEVICE TYPE
  180.   6.5 US MARKET ANALYSIS BY SERVICE TYPE
  181.   6.6 US MARKET ANALYSIS BY END USER
  182.   6.7 US MARKET ANALYSIS BY TEST PHASE
  183.   6.8 CANADA MARKET ANALYSIS BY TESTING TYPE
  184.   6.9 CANADA MARKET ANALYSIS BY DEVICE TYPE
  185.   6.10 CANADA MARKET ANALYSIS BY SERVICE TYPE
  186.   6.11 CANADA MARKET ANALYSIS BY END USER
  187.   6.12 CANADA MARKET ANALYSIS BY TEST PHASE
  188.   6.13 EUROPE MARKET ANALYSIS
  189.   6.14 GERMANY MARKET ANALYSIS BY TESTING TYPE
  190.   6.15 GERMANY MARKET ANALYSIS BY DEVICE TYPE
  191.   6.16 GERMANY MARKET ANALYSIS BY SERVICE TYPE
  192.   6.17 GERMANY MARKET ANALYSIS BY END USER
  193.   6.18 GERMANY MARKET ANALYSIS BY TEST PHASE
  194.   6.19 UK MARKET ANALYSIS BY TESTING TYPE
  195.   6.20 UK MARKET ANALYSIS BY DEVICE TYPE
  196.   6.21 UK MARKET ANALYSIS BY SERVICE TYPE
  197.   6.22 UK MARKET ANALYSIS BY END USER
  198.   6.23 UK MARKET ANALYSIS BY TEST PHASE
  199.   6.24 FRANCE MARKET ANALYSIS BY TESTING TYPE
  200.   6.25 FRANCE MARKET ANALYSIS BY DEVICE TYPE
  201.   6.26 FRANCE MARKET ANALYSIS BY SERVICE TYPE
  202.   6.27 FRANCE MARKET ANALYSIS BY END USER
  203.   6.28 FRANCE MARKET ANALYSIS BY TEST PHASE
  204.   6.29 RUSSIA MARKET ANALYSIS BY TESTING TYPE
  205.   6.30 RUSSIA MARKET ANALYSIS BY DEVICE TYPE
  206.   6.31 RUSSIA MARKET ANALYSIS BY SERVICE TYPE
  207.   6.32 RUSSIA MARKET ANALYSIS BY END USER
  208.   6.33 RUSSIA MARKET ANALYSIS BY TEST PHASE
  209.   6.34 ITALY MARKET ANALYSIS BY TESTING TYPE
  210.   6.35 ITALY MARKET ANALYSIS BY DEVICE TYPE
  211.   6.36 ITALY MARKET ANALYSIS BY SERVICE TYPE
  212.   6.37 ITALY MARKET ANALYSIS BY END USER
  213.   6.38 ITALY MARKET ANALYSIS BY TEST PHASE
  214.   6.39 SPAIN MARKET ANALYSIS BY TESTING TYPE
  215.   6.40 SPAIN MARKET ANALYSIS BY DEVICE TYPE
  216.   6.41 SPAIN MARKET ANALYSIS BY SERVICE TYPE
  217.   6.42 SPAIN MARKET ANALYSIS BY END USER
  218.   6.43 SPAIN MARKET ANALYSIS BY TEST PHASE
  219.   6.44 REST OF EUROPE MARKET ANALYSIS BY TESTING TYPE
  220.   6.45 REST OF EUROPE MARKET ANALYSIS BY DEVICE TYPE
  221.   6.46 REST OF EUROPE MARKET ANALYSIS BY SERVICE TYPE
  222.   6.47 REST OF EUROPE MARKET ANALYSIS BY END USER
  223.   6.48 REST OF EUROPE MARKET ANALYSIS BY TEST PHASE
  224.   6.49 APAC MARKET ANALYSIS
  225.   6.50 CHINA MARKET ANALYSIS BY TESTING TYPE
  226.   6.51 CHINA MARKET ANALYSIS BY DEVICE TYPE
  227.   6.52 CHINA MARKET ANALYSIS BY SERVICE TYPE
  228.   6.53 CHINA MARKET ANALYSIS BY END USER
  229.   6.54 CHINA MARKET ANALYSIS BY TEST PHASE
  230.   6.55 INDIA MARKET ANALYSIS BY TESTING TYPE
  231.   6.56 INDIA MARKET ANALYSIS BY DEVICE TYPE
  232.   6.57 INDIA MARKET ANALYSIS BY SERVICE TYPE
  233.   6.58 INDIA MARKET ANALYSIS BY END USER
  234.   6.59 INDIA MARKET ANALYSIS BY TEST PHASE
  235.   6.60 JAPAN MARKET ANALYSIS BY TESTING TYPE
  236.   6.61 JAPAN MARKET ANALYSIS BY DEVICE TYPE
  237.   6.62 JAPAN MARKET ANALYSIS BY SERVICE TYPE
  238.   6.63 JAPAN MARKET ANALYSIS BY END USER
  239.   6.64 JAPAN MARKET ANALYSIS BY TEST PHASE
  240.   6.65 SOUTH KOREA MARKET ANALYSIS BY TESTING TYPE
  241.   6.66 SOUTH KOREA MARKET ANALYSIS BY DEVICE TYPE
  242.   6.67 SOUTH KOREA MARKET ANALYSIS BY SERVICE TYPE
  243.   6.68 SOUTH KOREA MARKET ANALYSIS BY END USER
  244.   6.69 SOUTH KOREA MARKET ANALYSIS BY TEST PHASE
  245.   6.70 MALAYSIA MARKET ANALYSIS BY TESTING TYPE
  246.   6.71 MALAYSIA MARKET ANALYSIS BY DEVICE TYPE
  247.   6.72 MALAYSIA MARKET ANALYSIS BY SERVICE TYPE
  248.   6.73 MALAYSIA MARKET ANALYSIS BY END USER
  249.   6.74 MALAYSIA MARKET ANALYSIS BY TEST PHASE
  250.   6.75 THAILAND MARKET ANALYSIS BY TESTING TYPE
  251.   6.76 THAILAND MARKET ANALYSIS BY DEVICE TYPE
  252.   6.77 THAILAND MARKET ANALYSIS BY SERVICE TYPE
  253.   6.78 THAILAND MARKET ANALYSIS BY END USER
  254.   6.79 THAILAND MARKET ANALYSIS BY TEST PHASE
  255.   6.80 INDONESIA MARKET ANALYSIS BY TESTING TYPE
  256.   6.81 INDONESIA MARKET ANALYSIS BY DEVICE TYPE
  257.   6.82 INDONESIA MARKET ANALYSIS BY SERVICE TYPE
  258.   6.83 INDONESIA MARKET ANALYSIS BY END USER
  259.   6.84 INDONESIA MARKET ANALYSIS BY TEST PHASE
  260.   6.85 REST OF APAC MARKET ANALYSIS BY TESTING TYPE
  261.   6.86 REST OF APAC MARKET ANALYSIS BY DEVICE TYPE
  262.   6.87 REST OF APAC MARKET ANALYSIS BY SERVICE TYPE
  263.   6.88 REST OF APAC MARKET ANALYSIS BY END USER
  264.   6.89 REST OF APAC MARKET ANALYSIS BY TEST PHASE
  265.   6.90 SOUTH AMERICA MARKET ANALYSIS
  266.   6.91 BRAZIL MARKET ANALYSIS BY TESTING TYPE
  267.   6.92 BRAZIL MARKET ANALYSIS BY DEVICE TYPE
  268.   6.93 BRAZIL MARKET ANALYSIS BY SERVICE TYPE
  269.   6.94 BRAZIL MARKET ANALYSIS BY END USER
  270.   6.95 BRAZIL MARKET ANALYSIS BY TEST PHASE
  271.   6.96 MEXICO MARKET ANALYSIS BY TESTING TYPE
  272.   6.97 MEXICO MARKET ANALYSIS BY DEVICE TYPE
  273.   6.98 MEXICO MARKET ANALYSIS BY SERVICE TYPE
  274.   6.99 MEXICO MARKET ANALYSIS BY END USER
  275.   6.100 MEXICO MARKET ANALYSIS BY TEST PHASE
  276.   6.101 ARGENTINA MARKET ANALYSIS BY TESTING TYPE
  277.   6.102 ARGENTINA MARKET ANALYSIS BY DEVICE TYPE
  278.   6.103 ARGENTINA MARKET ANALYSIS BY SERVICE TYPE
  279.   6.104 ARGENTINA MARKET ANALYSIS BY END USER
  280.   6.105 ARGENTINA MARKET ANALYSIS BY TEST PHASE
  281.   6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY TESTING TYPE
  282.   6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY DEVICE TYPE
  283.   6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY SERVICE TYPE
  284.   6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
  285.   6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY TEST PHASE
  286.   6.111 MEA MARKET ANALYSIS
  287.   6.112 GCC COUNTRIES MARKET ANALYSIS BY TESTING TYPE
  288.   6.113 GCC COUNTRIES MARKET ANALYSIS BY DEVICE TYPE
  289.   6.114 GCC COUNTRIES MARKET ANALYSIS BY SERVICE TYPE
  290.   6.115 GCC COUNTRIES MARKET ANALYSIS BY END USER
  291.   6.116 GCC COUNTRIES MARKET ANALYSIS BY TEST PHASE
  292.   6.117 SOUTH AFRICA MARKET ANALYSIS BY TESTING TYPE
  293.   6.118 SOUTH AFRICA MARKET ANALYSIS BY DEVICE TYPE
  294.   6.119 SOUTH AFRICA MARKET ANALYSIS BY SERVICE TYPE
  295.   6.120 SOUTH AFRICA MARKET ANALYSIS BY END USER
  296.   6.121 SOUTH AFRICA MARKET ANALYSIS BY TEST PHASE
  297.   6.122 REST OF MEA MARKET ANALYSIS BY TESTING TYPE
  298.   6.123 REST OF MEA MARKET ANALYSIS BY DEVICE TYPE
  299.   6.124 REST OF MEA MARKET ANALYSIS BY SERVICE TYPE
  300.   6.125 REST OF MEA MARKET ANALYSIS BY END USER
  301.   6.126 REST OF MEA MARKET ANALYSIS BY TEST PHASE
  302.   6.127 KEY BUYING CRITERIA OF HEALTHCARE
  303.   6.128 RESEARCH PROCESS OF MRFR
  304.   6.129 DRO ANALYSIS OF HEALTHCARE
  305.   6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  306.   6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  307.   6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
  308.   6.133 HEALTHCARE, BY TESTING TYPE, 2024 (% SHARE)
  309.   6.134 HEALTHCARE, BY TESTING TYPE, 2024 TO 2035 (USD Billion)
  310.   6.135 HEALTHCARE, BY DEVICE TYPE, 2024 (% SHARE)
  311.   6.136 HEALTHCARE, BY DEVICE TYPE, 2024 TO 2035 (USD Billion)
  312.   6.137 HEALTHCARE, BY SERVICE TYPE, 2024 (% SHARE)
  313.   6.138 HEALTHCARE, BY SERVICE TYPE, 2024 TO 2035 (USD Billion)
  314.   6.139 HEALTHCARE, BY END USER, 2024 (% SHARE)
  315.   6.140 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
  316.   6.141 HEALTHCARE, BY TEST PHASE, 2024 (% SHARE)
  317.   6.142 HEALTHCARE, BY TEST PHASE, 2024 TO 2035 (USD Billion)
  318.   6.143 BENCHMARKING OF MAJOR COMPETITORS
  319. 7 LIST OF TABLES
  320.   7.1 LIST OF ASSUMPTIONS
  321.     7.1.1
  322.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  323.     7.2.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  324.     7.2.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  325.     7.2.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  326.     7.2.4 BY END USER, 2025-2035 (USD Billion)
  327.     7.2.5 BY TEST PHASE, 2025-2035 (USD Billion)
  328.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  329.     7.3.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  330.     7.3.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  331.     7.3.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  332.     7.3.4 BY END USER, 2025-2035 (USD Billion)
  333.     7.3.5 BY TEST PHASE, 2025-2035 (USD Billion)
  334.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  335.     7.4.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  336.     7.4.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  337.     7.4.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  338.     7.4.4 BY END USER, 2025-2035 (USD Billion)
  339.     7.4.5 BY TEST PHASE, 2025-2035 (USD Billion)
  340.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  341.     7.5.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  342.     7.5.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  343.     7.5.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  344.     7.5.4 BY END USER, 2025-2035 (USD Billion)
  345.     7.5.5 BY TEST PHASE, 2025-2035 (USD Billion)
  346.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  347.     7.6.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  348.     7.6.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  349.     7.6.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  350.     7.6.4 BY END USER, 2025-2035 (USD Billion)
  351.     7.6.5 BY TEST PHASE, 2025-2035 (USD Billion)
  352.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  353.     7.7.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  354.     7.7.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  355.     7.7.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  356.     7.7.4 BY END USER, 2025-2035 (USD Billion)
  357.     7.7.5 BY TEST PHASE, 2025-2035 (USD Billion)
  358.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  359.     7.8.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  360.     7.8.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  361.     7.8.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  362.     7.8.4 BY END USER, 2025-2035 (USD Billion)
  363.     7.8.5 BY TEST PHASE, 2025-2035 (USD Billion)
  364.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  365.     7.9.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  366.     7.9.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  367.     7.9.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  368.     7.9.4 BY END USER, 2025-2035 (USD Billion)
  369.     7.9.5 BY TEST PHASE, 2025-2035 (USD Billion)
  370.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  371.     7.10.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  372.     7.10.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  373.     7.10.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  374.     7.10.4 BY END USER, 2025-2035 (USD Billion)
  375.     7.10.5 BY TEST PHASE, 2025-2035 (USD Billion)
  376.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  377.     7.11.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  378.     7.11.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  379.     7.11.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  380.     7.11.4 BY END USER, 2025-2035 (USD Billion)
  381.     7.11.5 BY TEST PHASE, 2025-2035 (USD Billion)
  382.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  383.     7.12.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  384.     7.12.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  385.     7.12.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  386.     7.12.4 BY END USER, 2025-2035 (USD Billion)
  387.     7.12.5 BY TEST PHASE, 2025-2035 (USD Billion)
  388.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  389.     7.13.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  390.     7.13.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  391.     7.13.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  392.     7.13.4 BY END USER, 2025-2035 (USD Billion)
  393.     7.13.5 BY TEST PHASE, 2025-2035 (USD Billion)
  394.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  395.     7.14.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  396.     7.14.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  397.     7.14.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  398.     7.14.4 BY END USER, 2025-2035 (USD Billion)
  399.     7.14.5 BY TEST PHASE, 2025-2035 (USD Billion)
  400.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  401.     7.15.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  402.     7.15.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  403.     7.15.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  404.     7.15.4 BY END USER, 2025-2035 (USD Billion)
  405.     7.15.5 BY TEST PHASE, 2025-2035 (USD Billion)
  406.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  407.     7.16.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  408.     7.16.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  409.     7.16.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  410.     7.16.4 BY END USER, 2025-2035 (USD Billion)
  411.     7.16.5 BY TEST PHASE, 2025-2035 (USD Billion)
  412.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  413.     7.17.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  414.     7.17.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  415.     7.17.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  416.     7.17.4 BY END USER, 2025-2035 (USD Billion)
  417.     7.17.5 BY TEST PHASE, 2025-2035 (USD Billion)
  418.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  419.     7.18.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  420.     7.18.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  421.     7.18.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  422.     7.18.4 BY END USER, 2025-2035 (USD Billion)
  423.     7.18.5 BY TEST PHASE, 2025-2035 (USD Billion)
  424.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  425.     7.19.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  426.     7.19.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  427.     7.19.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  428.     7.19.4 BY END USER, 2025-2035 (USD Billion)
  429.     7.19.5 BY TEST PHASE, 2025-2035 (USD Billion)
  430.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  431.     7.20.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  432.     7.20.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  433.     7.20.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  434.     7.20.4 BY END USER, 2025-2035 (USD Billion)
  435.     7.20.5 BY TEST PHASE, 2025-2035 (USD Billion)
  436.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  437.     7.21.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  438.     7.21.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  439.     7.21.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  440.     7.21.4 BY END USER, 2025-2035 (USD Billion)
  441.     7.21.5 BY TEST PHASE, 2025-2035 (USD Billion)
  442.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  443.     7.22.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  444.     7.22.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  445.     7.22.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  446.     7.22.4 BY END USER, 2025-2035 (USD Billion)
  447.     7.22.5 BY TEST PHASE, 2025-2035 (USD Billion)
  448.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  449.     7.23.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  450.     7.23.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  451.     7.23.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  452.     7.23.4 BY END USER, 2025-2035 (USD Billion)
  453.     7.23.5 BY TEST PHASE, 2025-2035 (USD Billion)
  454.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  455.     7.24.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  456.     7.24.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  457.     7.24.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  458.     7.24.4 BY END USER, 2025-2035 (USD Billion)
  459.     7.24.5 BY TEST PHASE, 2025-2035 (USD Billion)
  460.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  461.     7.25.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  462.     7.25.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  463.     7.25.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  464.     7.25.4 BY END USER, 2025-2035 (USD Billion)
  465.     7.25.5 BY TEST PHASE, 2025-2035 (USD Billion)
  466.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  467.     7.26.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  468.     7.26.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  469.     7.26.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  470.     7.26.4 BY END USER, 2025-2035 (USD Billion)
  471.     7.26.5 BY TEST PHASE, 2025-2035 (USD Billion)
  472.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  473.     7.27.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  474.     7.27.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  475.     7.27.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  476.     7.27.4 BY END USER, 2025-2035 (USD Billion)
  477.     7.27.5 BY TEST PHASE, 2025-2035 (USD Billion)
  478.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  479.     7.28.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  480.     7.28.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  481.     7.28.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  482.     7.28.4 BY END USER, 2025-2035 (USD Billion)
  483.     7.28.5 BY TEST PHASE, 2025-2035 (USD Billion)
  484.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  485.     7.29.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  486.     7.29.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  487.     7.29.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  488.     7.29.4 BY END USER, 2025-2035 (USD Billion)
  489.     7.29.5 BY TEST PHASE, 2025-2035 (USD Billion)
  490.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  491.     7.30.1 BY TESTING TYPE, 2025-2035 (USD Billion)
  492.     7.30.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
  493.     7.30.3 BY SERVICE TYPE, 2025-2035 (USD Billion)
  494.     7.30.4 BY END USER, 2025-2035 (USD Billion)
  495.     7.30.5 BY TEST PHASE, 2025-2035 (USD Billion)
  496.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  497.     7.31.1
  498.   7.32 ACQUISITION/PARTNERSHIP
  499.     7.32.1

Healthcare Market Segmentation

Healthcare By Testing Type (USD Billion, 2025-2035)

  • Biological Testing
  • Chemical Testing
  • Physical Testing
  • Sterilization Testing

Healthcare By Device Type (USD Billion, 2025-2035)

  • In-Vitro Diagnostic Devices
  • Surgical Instruments
  • Patient Monitoring Devices
  • Therapeutic Equipment

Healthcare By Service Type (USD Billion, 2025-2035)

  • Quality Control Testing
  • Regulatory Compliance Testing
  • Research and Development Testing
  • Stability Testing

Healthcare By End User (USD Billion, 2025-2035)

  • Medical Device Manufacturers
  • Contract Research Organizations
  • Pharmaceutical Companies
  • Academic Institutions

Healthcare By Test Phase (USD Billion, 2025-2035)

  • Preclinical Testing
  • Clinical Testing
  • Post-Market Surveillance

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions